TRB Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$381K Buy
728
+17
+2% +$8.7K 0.05% 179
2026
Q2
$353K Hold
711
– – 0.05% 185
2026
Q1
$317K Buy
+711
New +$332K 0.05% 200

Other funds holding VRTX

TRB Wealth Management's VRTX Position: Q3 2026 in Review

TRB Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q3 2026, buying an estimated $8.7K and bringing the position to 728 shares worth $381K. The position accounts for 0.05% of the portfolio, ranked #179.

TRB Wealth Management first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • TRB Wealth Management held 728 shares of Vertex Pharmaceuticals worth $381K as of Q3 2026.
  • TRB Wealth Management bought 17 Vertex Pharmaceuticals shares in Q3 2026, an estimated $8.7K.
  • Vertex Pharmaceuticals made up 0.05% of TRB Wealth Management's portfolio in Q3 2026, its #179 holding.
  • TRB Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.